E N Janoff - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E N Janoff

Showing results (71-80 of 75) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 75 results.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995

Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complexS Kline, T A Larsen, L Fieber, et al.

AIDS Research and Human Retroviruses|June 25, 1999

Immune activation and virologic response to immunization in recent HIV type 1 seroconvertersE N Janoff, S A Tasker, M Stevenson, et al.

Nature Medicine|September 2, 1999

HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophagesS Swingler, A Mann, J Jacqué, et al.

American Journal of Respiratory and Critical Care Medicine|April 1, 1996

Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumoniaJ B Rubins, D Charboneau, C Fasching, et al.

Lancet (London, England)|July 21, 2000

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trialN French, J Nakiyingi, L M Carpenter, et al.

Pageof 8

Search research articles

Showing results (71-80 of 75) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 75 results.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995

Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complexS Kline, T A Larsen, L Fieber, et al.

AIDS Research and Human Retroviruses|June 25, 1999

Immune activation and virologic response to immunization in recent HIV type 1 seroconvertersE N Janoff, S A Tasker, M Stevenson, et al.

Nature Medicine|September 2, 1999

HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophagesS Swingler, A Mann, J Jacqué, et al.

American Journal of Respiratory and Critical Care Medicine|April 1, 1996

Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumoniaJ B Rubins, D Charboneau, C Fasching, et al.

Lancet (London, England)|July 21, 2000

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trialN French, J Nakiyingi, L M Carpenter, et al.

Pageof 8